Arca
Skip to content

HCK: Tyrosine-protein kinase HCK

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Non-receptor tyrosine-protein kinase found in hematopoietic cells that transmits signals from cell surface receptors and plays an important role in the regulation of innate immune responses, including neutrophil, monocyte, macrophage and mast cell functions, phagocytosis, cell survival and proliferation, cell adhesion and migration.

  • Drugs that act on it: 1
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
DrugUS approvalMechanismActionWarnings
BosutinibApprovedTyrosine-protein kinase HCK inhibitorInhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Neoplasm
0.49
Neurodegenerative disease
0.42
Autoinflammation with pulmonary and cutaneous vasculitis
0.40
HIV infectious disease
0.37
Hypertensive disorder
0.35

Genes and Related Targets

Complexes and families that share a gene with this target
Genes
HCK
Related
SRC

Drugs and mechanisms are from ChEMBL CHEMBL3234 (CC BY-SA 3.0). Gene name, function (UniProt P08631, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.